UBS Group
IPX

UBS Group’s IperionX IPX Stock Holding History

UBS Group’s Portfolio IPX Stock Details IPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Buy
63,872
+33,917
+113% +$1.44M ﹤0.01% 5132
2025
Q4 		$1.08M Sell
29,955
-9,593
-24% -$393K ﹤0.01% 5494
2025
Q3 		$1.95M Sell
39,548
-10,233
-21% -$415K ﹤0.01% 4973
2025
Q2 		$1.57M Sell
49,781
-812
-2% -$18.3K ﹤0.01% 5052
2025
Q1 		$910K Buy
+50,593
New +$1.26M ﹤0.01% 5364
2024
Q4 		– Sell
-431
Closed -$9.6K – 10160
2024
Q3 		$9.6K Buy
+431
New +$7.06K ﹤0.01% 7784
2023
Q2 		– Sell
-216
Closed -$1.11K – 9249
2023
Q1 		$1.11K Buy
+216
New +$1.26K ﹤0.01% 8810

Other funds holding IPX

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

UBS Group's IPX Position: Q1 2026 in Review

UBS Group increased its IperionX (IPX) stake by 113% in Q1 2026, buying an estimated $1.44M and bringing the position to 63,872 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #5132.

UBS Group first reported a position in IPX in Q1 2023 and has held it in 7 quarters since. The position peaked at $1.95M in Q3 2025. 45 funds tracked by Wall St. Rank hold IPX as of Q1 2026.

  • UBS Group held 63,872 shares of IperionX worth $1.66M as of Q1 2026.
  • UBS Group bought 33,917 IperionX shares in Q1 2026, an estimated $1.44M.
  • IperionX made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5132 holding.
  • UBS Group first reported a position in IperionX in Q1 2023 and has held it in 7 quarters since.
  • UBS Group's IperionX position peaked at $1.95M in Q3 2025.
  • 45 funds tracked by Wall St. Rank held IperionX as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.